Michael Giovingo
John H. Stroger, Jr. Hospital of Cook County
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Giovingo.
Journal of Glaucoma | 2007
M. J. Nolan; Michael Giovingo; Am Miller; Robert D. Wertz; Robert Ritch; Jeffrey M. Liebmann; R. Rand Allingham; Leon W. Herndon; Martin B. Wax; Regina Smolyak; Fareed Hasan; Edward M. Barnett; John R. Samples; Paul A. Knepper
PurposeTo correlate aqueous humor soluble CD44 (sCD44) concentration, visual field loss, and glaucoma risk factors in primary open-angle glaucoma (POAG) patients. MethodsAqueous samples were obtained by paracentesis from normal and glaucoma patients who were undergoing elective surgery and analyzed for sCD44 concentration by enzyme-linked immunosorbent assay. ResultsIn normal aqueous (n=124) the sCD44 concentration was 5.88±0.27 ng/mL, whereas in POAG aqueous (n=90) the sCD44 concentration was 12.76±0.66 ng/mL, a 2.2-fold increase (P<0.000001). In POAG patients with prior successful filtration surgery (n=13), the sCD44 concentration was decreased by 43% to 7.32±1.44 (P=0.001) in comparison with POAG patients without filtration surgery; however, the sCD44 concentration in the prior successful filtration subgroup with no medications and normal intraocular pressure was 12.62±3.81 (P=0.05) compared with normal. The sCD44 concentration of normal pressure glaucoma patients was 9.19±1.75 ng/mL, a 1.6-fold increase compared with normal (P=0.02). Race and intraocular pressure pulse amplitude were significant POAG risk factors in this cohort of patients. In both normal and POAG patients with mild and moderate visual field loss, sCD44 concentration was greater in African Americans than in whites (P=0.04) ConclusionssCD44 concentration in the aqueous of POAG patients correlated with the severity of visual field loss in all stages in white patients and in mild to moderate stages in African American patients. sCD44 concentration in aqueous is a possible protein biomarker of visual field loss in POAG.
Investigative Ophthalmology & Visual Science | 2015
Louis R. Pasquale; Akiko Hanyuda; Ai Ren; Michael Giovingo; Scott H. Greenstein; Clara C. Cousins; Thomas Patrianakos; Angelo P. Tanna; Christopher Wanderling; William Norkett; Janey L. Wiggs; Kelsey Green; Jae H. Kang; Paul A. Knepper
PURPOSE There is considerable evidence for systemic vascular dysfunction in primary open-angle glaucoma (POAG). We performed nailfold capillary video microscopy to observe directly the nature of nonocular microvasculature abnormalities in POAG. METHODS We enrolled 199 POAG patients and 124 control subjects from four sites. We used JH-1004 capillaroscopes to perform nailfold capillary video microscopy on the fourth and fifth digits of each subjects nondominant hand. Videos were evaluated for hemorrhages, dilated capillary loops > 50 μm, and avascular zones > 100 μm by graders masked to case status. Multivariable odds ratios (ORs) and 95% confidence intervals (CIs) for POAG were obtained by means of logistic regression analyses that were applied to data from all cases and controls. Corresponding estimates of moderate or severe POAG versus mild POAG (based on the Hodapp-Anderson-Parrish scale) were obtained among cases only. RESULTS After controlling for demographic factors, family history of glaucoma, systemic diseases, and use of anticoagulation and antiplatelet therapy, for each 100 nailfold capillaries assessed, all types of microvascular abnormalities were significantly associated with POAG. Specifically, the presence of any dilated capillaries (OR = 2.9; 95% CI, 1.6-5.6), avascular zones (OR = 4.4; 95% CI, 1.7-11.3) and hemorrhages (OR = 12.2; 95% CI, 5.9-25.1) were associated with POAG. Among cases, the frequency of microvascular abnormalities was not associated with glaucoma severity (P ≥ 0.43). CONCLUSIONS These data provided support for nonocular capillary bed abnormalities in POAG. Comparable vascular abnormalities in the optic nerve may render it susceptible to glaucomatous damage.
Investigative Ophthalmology & Visual Science | 2013
M. J. Nolan; T. Koga; Loyal Walker; Ryan D. McCarty; Algis Grybauskas; Michael Giovingo; Kevin Skuran; Paulius V Kuprys; Paul A. Knepper
PURPOSE To determine whether soluble CD44 (sCD44), a likely biomarker of primary open-angle glaucoma (POAG), is internalized in cultured human trabecular meshwork (TM) cells and trafficked to mitochondria. METHODS In vitro, 32-kD sCD44 was isolated from human sera, biotinylated, and dephosphorylated. TM cells were incubated for 1 hour at 4°C with biotinylated albumin (b-albumin), biotin-labeled sCD44 (b-sCD44), or hypophosphorylated biotin-labeled sCD44 (-p b-sCD44) in the presence or absence of unlabeled sCD44, hyaluronic acid (HA), and a selected 10-mer HA binding peptide. The slides were warmed for 1 or 2 hours at 37°C, and 125 nM MitoTracker Red was added for the last 20 minutes of the incubation. The cells were washed, fixed, incubated with anti-biotin antibody and FITC-labeled goat anti-mouse antibody, and examined under a confocal microscope. RESULTS TM cell membranes were positive for b-sCD44 after 4°C incubation. When the temperature was raised to 37°C, b-sCD44 or -p b-sCD44 appeared in the cytoplasm. The internalization of b-sCD44 was blocked by excess unlabeled sCD44, HA, and a 10-mer HA-binding peptide. Double label experiments with b-sCD44 or -p b-sCD44 and MitoTracker Red indicated partial overlap. The percent co-localization of MitoTracker Red at 2 hours and FITC -p b-sCD44 was 17.4% (P < 0.001) and for FITC b-sCD44 was 11.7% (P < 0.001) compared with b-albumin. The influence of putative CD44 phosphorylation sites on mitochondrial trafficking was determined by TargetP 1.1. CONCLUSIONS sCD44 is internalized by TM cells and trafficked in part to mitochondria, which may be a factor in the toxicity of sCD44 in the POAG disease process.
Experimental Eye Research | 2018
Kate E. Keller; Sanjoy K. Bhattacharya; Theresa Borrás; Thomas M. Brunner; Sunee Chansangpetch; Abbott F. Clark; W. Michael Dismuke; Yiqin Du; Michael H. Elliott; C. Ross Ethier; Jennifer A. Faralli; Thomas F. Freddo; Rudolf Fuchshofer; Michael Giovingo; Haiyan Gong; Pedro Gonzalez; Alex S. Huang; Murray Johnstone; Paul L. Kaufman; Mary J. Kelley; Paul A. Knepper; Casey Kopczynski; John Kuchtey; Rachel W. Kuchtey; Markus H. Kuehn; Raquel L. Lieberman; Shan C. Lin; Paloma B. Liton; Yutao Liu; Elke Lütjen-Drecoll
Cultured trabecular meshwork (TM) cells are a valuable model system to study the cellular mechanisms involved in the regulation of conventional outflow resistance and thus intraocular pressure; and their dysfunction resulting in ocular hypertension. In this review, we describe the standard procedures used for the isolation of TM cells from several animal species including humans, and the methods used to validate their identity. Having a set of standard practices for TM cells will increase the scientific rigor when used as a model, and enable other researchers to replicate and build upon previous findings.
Molecular Vision | 2013
Michael Giovingo; M. J. Nolan; Ryan D. McCarty; Iok Hou Pang; Abbot F. Clark; R. M. Beverley; Steven M. Schwartz; W. Daniel Stamer; Loyal Walker; Algis Grybauskas; Kevin Skuran; Paulius V Kuprys; Beatrice Y. J. T. Yue; Paul A. Knepper
Investigative Ophthalmology & Visual Science | 2008
Michael Giovingo; M. J. Nolan; T. Koga; Beatrice Y. J. T. Yue; Robert D. Wertz; Robert Ritch; A. Shepard; Abbot F. Clark; Martin B. Wax; Paul A. Knepper
Investigative Ophthalmology & Visual Science | 2017
Michael David Miazga; Indre Bielskus; Nicholas Maxwell Pfahler; Angelo P. Tanna; Nicholas J. Volpe; Michael Giovingo; Zibute Zaparackas; Paul A. Knepper
Investigative Ophthalmology & Visual Science | 2017
Paul A. Knepper; Kovas Polikaitis; Michael Giovingo; Kevin Carey; Indre Bielskus; Michael David Miazga; Nicholas Maxwell Pfahler; Jeffrey Ma; Nicholas J. Volpe
Investigative Ophthalmology & Visual Science | 2017
Krishna Patel; Nathaniel Gelinas; Hammad Rafay; Thomas Patrianakos; Michael Giovingo
Investigative Ophthalmology & Visual Science | 2017
Michael Giovingo; Kevin Carey; Indre Bielskus; Michael David Miazga; Nicholas Maxwell Pfahler; J. R. Samples; Paul A. Knepper